Serological Biomarkers and Indices for the Current Activity and Prognosis of ANCA-Associated Vasculitis: Experience in a Single Centre in Korea

키워드

참고문헌 (76)

1. Jennette JC, "2012 revised international chapel hill consensus conference nomenclature of vasculitides", Arthritis Rheum, 65, pp.1~11 (2013)
2. Watts R, "Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies", Ann Rheum Dis, 66, pp.222~227 (2007)
3. Mukhtyar C, "Modification and validation of the Birmingham Vasculitis Activity Score(version 3)", Ann Rheum Dis, 68, pp.1827~1832 (2009)
4. Guillevin L, "The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort", Medicine(Baltimore), 90, pp.19~27 (2011)
5. Bhamra K, "Damage assessment in ANCA-associated vasculitis", Curr Rheumatol Rep, 14, pp.494~500 (2012)
6. Han CW, "Development of the Korean version of Short-Form 36-Item Health Survey : health related QOL of healthy elderly people and elderly patients in Korea", Tohoku J Exp Med, 203, pp.189~194 (2004)
7. Jennette JC, "Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease", Nat Rev Rheumatol, 10, pp.463~473 (2014)
8. 최찬범, "Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review", Yonsei Medical Journal, 60(1), pp.10~21 (2019), 연세대학교의과대학[DOI]
9. Lamprecht P, "Pathogenetic and clinical aspects of anti-neutrophil cytoplasmic autoantibody-associated vasculitides", Front Immunol, 9, pp.680~ (2018)
10. Strimbu K, "What are biomarkers?", Curr Opin HIV AIDS, 5, pp.463~466 (2010)
12. Nimse SB, "Biomarker detection technologies and future directions", Analyst, 141, pp.740~755 (2016)
13. Fall DJ, "Utilization of translational bioinformatics to identify novel biomarkers of bortezomib resistance in multiple myeloma", J Cancer, 5, pp.720~727 (2014)
14. Koh JH, "Editorial: can an Increase in antineutrophil cytoplasmic autoantibody titer predict relapses in antineutrophil cytoplasmic antibody-associated vasculitis?", Arthritis Rheumatol, 68, pp.1571~1573 (2016)
15. Lally L, "Biomarkers in ANCA-associated vasculitis", Curr Rheumatol Rep, 15, pp.363~ (2013)
16. Kain R, "High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis", J Am Soc Nephrol, 23, pp.556~566 (2012)
17. Hao J, "The association between anti-plasminogen antibodies and disease activity in ANCAassociated vasculitis", Rheumatology(Oxford), 53, pp.300~306 (2014)
18. Suzuki K, "Proposal of anti-moesin as a novel biomarker for ANCA-associated vasculitis", Clin Exp Nephrol, 17, pp.638~641 (2013)
19. Simon A, "Detection of anti-pentraxin-3 autoantibodies in ANCA-associated vasculitis", PLoS One, 11, pp.e0147091~ (2016)
20. Nagai M, "Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis : association with disease activity", Nephron Clin Pract, 118, pp.c339~45 (2011)
21. London J, "Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis", Rheumatology (Oxford) (2020)[DOI]
22. Brilland B, "Complement alternative pathway in ANCA-associated vasculitis : two decades from bench to bedside", Autoimmun Rev, 19, pp.102424~ (2020)
23. Kraaij T, "Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA", Kidney Int, 94, pp.139~149 (2018)
24. Söderberg D, "Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission", Rheumatology(Oxford), 54, pp.2085~2094 (2015)
25. Tedesco M, "Update on ANCA-associated vasculitis : from biomarkers to therapy", J Nephrol, 32, pp.871~882 (2019)
26. Burska A, "Cytokines as biomarkers in rheumatoid arthritis", Mediators Inflamm, 2014, pp.545493~ (2014)
27. Stypin´ska B, "Cytokines and microRNAs as candidate biomarkers for systemic lupus erythematosus", Int J Mol Sci, 16, pp.24194~24218 (2015)
28. Berti A, "The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis", J Autoimmun, 105, pp.102302~ (2019)
29. Wang Y, "Reduced activated regulatory T cells and imbalance of Th17", activated Treg cells marks renal involvement in ANCA-associated vasculitis, 2020, pp.118, 19~29
30. Berti A, "Brief report : circulating cytokine profiles and antineutrophil cytoplasmic antibody specificity in patients with antineutrophil cytoplasmic antibody-associated vasculitis", Arthritis Rheumatol, 70, pp.1114~1121 (2018)
31. Kim MK, "Multivariable index for assessing the activity and predicting all-cause mortality in antineutrophil cytoplasmic antibody-associated vasculitis", J Clin Lab Anal, 34, pp.e23022~ (2020)
32. Iwai N, "Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer", Sci Rep, 10, pp.18758~ (2020)
33. Wu M, "Preoperative plus postoperative neutrophil-lymphocyte ratio for predicting overall survival following partial hepatectomy for hepatocellular carcinoma", Oncol Lett, 20, pp.375~ (2020)
34. Firizal AS, "Cut off point of neutrophil-tolymphocyte ratio as a marker of active disease in systemic lupus erythematosus", Lupus, 29, pp.1566~1570 (2020)
35. Chandrashekara S, "Potential of neutrophil to lymphocyte ratio in predicting sustained remission in rheumatoid arthritis compared to other immune activation markers", Indian J Med Res, 152, pp.234~243 (2020)
36. Coskun Kaya, "HALP score and albumin levels in men with prostate cancer and benign prostate hyperplasia", International Journal of Clinical Practice, 75(3) (2021), Hindawi Limited[DOI]
37. Zhang CC, "Preoperative inversed albumin-to-globulin ratio predicts worse oncologic prognosis following curative hepatectomy for hepatocellular carcinoma", Cancer Manag Res, 12, pp.9929~9939 (2020)
38. Chung JW, "The prognostic role of preoperative serum albumin", globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy, 2020, pp.10, 11999~
39. Stohl W, "Elevated serum globulin gap as a highly reliable marker of elevated erythrocyte sedimentation rate in patients with systemic rheumatic diseases", Semin Arthritis Rheum, 49, pp.485~492 (2019)
40. Kim HJ, "Mean platelet volume can estimate the current vasculitis activity of microscopic polyangiitis", Rheumatol Int, 38, pp.1095~1101 (2018)
41. Mun CH, "Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1(AIMP1)antibody significantly improves nephritis in(NZB", NZW)F1 mice, 2019, pp.220, 119408~
42. Ahn SS, "Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1can predict severe antineutrophil cytoplasmic antibody-associated vasculitis : a pilot monocentric study", Biomed Res Int, 2019, pp.7508240~ (2019)
43. Tangye SG, "Regulation of the germinal center and humoral immunity by interleukin-21", J Exp Med, 217, pp.e20191638~ (2020)
44. Yoon T, "Serum interleukin-21positivity could indicate the current activity of antineutrophil cytoplasmic antibody-associated vasculitis : a monocentric prospective study", Clin Rheumatol, 38, pp.1685~1690 (2019)
45. Keir ME, "PD-1 and its ligands in tolerance and immunity", Annu Rev Immunol, 26, pp.677~704 (2008)
46. Nielsen C, "Alternative splice variants of the human PD-1 gene", Cell Immunol, 235, pp.109~116 (2005)
47. Yoon T, "Serum soluble programmed cell death protein 1 could predict the current activity and severity of antineutrophil cytoplasmic antibody-associated vasculitis : a monocentric prospective study", Clin Exp Rheumatol, 37(Suppl 117), pp.116~121 (2019)
48. Wilson KC, "The effect of interleukin-16 and its precursor on T lymphocyte activation and growth", Growth Factors, 22, pp.97~104 (2004)
49. Yoon T, "Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis", Arthritis Res Ther, 22, pp.73~ (2020)
50. Chen M, "LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells : implications in endothelial dysfunction and atherosclerosis", Pharmacol Ther, 95, pp.89~100 (2002)
51. Pirillo A, "Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosisrelated diseases", Dis Markers, 35, pp.413~418 (2013)
52. Ishikawa M, "Lectin-like oxidized low-density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis", Arthritis Rheum, 64, pp.1024~1034 (2012)
53. 윤태준, "Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Is Inversely Correlated with the Activity of ANCA-Associated Vasculitis", Yonsei Medical Journal, 61(8), pp.720~725 (2020), 연세대학교의과대학[DOI]
54. Pa˛gowska-Klimek I, "Mannan-binding lectin in cardiovascular disease", Biomed Res Int, 2014, pp.616817~ (2014)
55. Yoon T, "Serum mannose-binding lectin levels are correlated with the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis : a single-center study", Tohoku J Exp Med, 251, pp.117~123 (2020)
56. Field D, "Performance evaluation of the immature granulocyte parameter on the Sysmex XE-2100 automated hematology analyzer", Lab Hematol, 12, pp.11~14 (2006)
57. 유주영, "Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis", Yonsei Medical Journal, 59(3), pp.397~405 (2018), 연세대학교의과대학[DOI]
58. Luo R, "Prognostic value of red blood cell distribution width in non-cardiovascular critically or acutely patients : a systematic review", PLoS One, 11, pp.e0167000~ (2016)
59. Rodríguez-Carrio J, "Red cell distribution width is associated with cardiovascular risk and disease parameters in rheumatoid arthritis", Rheumatology(Oxford), 54, pp.641~646 (2015)
60. 김호재, "Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis", Yonsei Medical Journal, 59(2), pp.294~302 (2018), 연세대학교의과대학[DOI]
61. 문재승, "C-Reactive Protein to Serum Albumin Ratio Is an Independent Predictor of All-Cause Mortality in Patients with ANCA-Associated Vasculitis", Yonsei Medical Journal, 59(7), pp.865~871 (2018), 연세대학교의과대학[DOI]
62. Schulze-Koops H, "Lymphopenia and autoimmune diseases", Arthritis Res Ther, 6, pp.178~180 (2004)
63. Ahn SS, "Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis : a retrospective study", BMC Nephrol, 19, pp.187~ (2018)
64. Armen Yuri Gasparyan, "The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases", Annals of Laboratory Medicine, 39(4), pp.345~357 (2019), 대한진단검사의학회[DOI]
65. Park HJ, "Platelet to lymphocyte ratio is associated with the current activity of ANCA-associated vasculitis at diagnosis : a retrospective monocentric study", Rheumatol Int, 38, pp.1865~1871 (2018)
66. Xu PC, "Hypoalbuminaemia in antineutrophil cytoplasmic antibody-associated vasculitis : incidence and significance", Clin Exp Rheumatol, 36, pp.603~611 (2018)
67. O’Connell TX, "Understanding and interpreting serum protein electrophoresis", Am Fam Physician, 71, pp.105~112 (2005)
68. Ahn SS, "Clinical role of albumin to globulin ratio in microscopic polyangiitis : a retrospective monocentric study", Clin Rheumatol, 38, pp.487~494 (2019)
69. Nakagomi A, "Nutritional status is associated with inflammation and predicts a poor outcome in patients with chronic heart failure", J Atheroscler Thromb, 23, pp.713~727 (2016)
70. 안성수, "Controlling Nutritional Status Score is Associated with All-Cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis", Yonsei Medical Journal, 60(12), pp.1164~1173 (2019), 연세대학교의과대학[DOI]
71. Hu B, "Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma", Clin Cancer Res, 20, pp.6212~6222 (2014)
72. Kim Y, "Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis", Nephrology(Carlton), 24, pp.711~717 (2019)
73. Peng D, "Prognostic significance of HALP(hemoglobin, albumin, lymphocyte and platelet)in patients with bladder cancer after radical cystectomy", Sci Rep, 8, pp.794~ (2018)
74. Park PG, "Will the HALP score help to assess the activity and predict the prognosis of antineutrophil cytoplasmic antibody-associated vasculitis?", Clin Exp Rheumatol, 38(Suppl 124), pp.236~237 (2020)
75. Wu TT, "Atherogenic index of plasma(AIP) : a novel predictive indicator for the coronary artery disease in postmenopausal women", Lipids Health Dis, 17, pp.197~ (2018)
76. Ahn SS, "Atherogenic index of plasma predicts cerebrovascular accident occurrence in antineutrophil cytoplasmic antibody-associated vasculitis", Lipids Health Dis, 19, pp.184~ (2020)

관련 논문AI추천